MedPath

HEIDELBERG UNIVERSITY

🇺🇸United States
Ownership
-
Established
1386-01-01
Employees
-
Market Cap
-
Website
https://www.uni-heidelberg.de/

Comparison of Dialysis Strategies in Critically Ill Patients With Acute Renal Failure

Not Applicable
Completed
Conditions
Dialysis
Acute Renal Failure
Interventions
Procedure: Renal replacement therapy
First Posted Date
2006-05-08
Last Posted Date
2012-08-24
Lead Sponsor
Heidelberg University
Target Recruit Count
230
Registration Number
NCT00322530
Locations
🇩🇪

Division of Nephrology, University of Heidelberg, Heidelberg, Baden-Wurttemberg, Germany

Safety Study of Cetuximab, Radiotherapy and Temozolomide in Primary Glioblastoma Multiforme(GERT)

Phase 1
Conditions
Glioblastoma Multiforme
First Posted Date
2006-04-06
Last Posted Date
2006-09-08
Lead Sponsor
Heidelberg University
Target Recruit Count
46
Registration Number
NCT00311857
Locations
🇩🇪

University of Heidelberg, Heidelberg, Baden-Württemberg, Germany

Local Application of Autologous Bone Marrow Cells for Treatment of Chronic Diabetic Ulcers

Phase 1
Conditions
Diabetic Foot
Diabetes Complications
First Posted Date
2006-02-15
Last Posted Date
2010-01-18
Lead Sponsor
Heidelberg University
Target Recruit Count
40
Registration Number
NCT00292357
Locations
🇩🇪

Medizinische Klinik 1, Universitätsklinikum Heidelberg, Heidelberg, Germany

Whole Body Washing With Chlorhexidine for the Eradication of MRSA

Phase 2
Completed
Conditions
MRSA-Colonization
First Posted Date
2005-12-16
Last Posted Date
2005-12-16
Lead Sponsor
Heidelberg University
Target Recruit Count
100
Registration Number
NCT00266448
Locations
🇩🇪

University Hospital Heidelberg, Heidelberg, Germany

Stress-relief Management for Treatment of Late Complications in Type 2 Diabetes

Not Applicable
Conditions
Albuminuria
Diabetes Mellitus, Type 2
Diabetes Complications
First Posted Date
2005-12-08
Last Posted Date
2011-10-27
Lead Sponsor
Heidelberg University
Target Recruit Count
110
Registration Number
NCT00263419
Locations
🇩🇪

Department of Medicine, University of Heidelberg, Heidelberg, Germany

Efficacy of Amodiaquine in the Treatment of Uncomplicated Falciparum Malaria in Young Children of Burkina Faso

Phase 2
Completed
Conditions
Malaria
First Posted Date
2005-12-02
Last Posted Date
2010-02-03
Lead Sponsor
Heidelberg University
Target Recruit Count
120
Registration Number
NCT00261222
Locations
🇧🇫

Centre de Recherche en Santé de Nouna (CRSN), Nouna, Burkina Faso

Retarded Phosphatidylcholine Versus Mesalazin in Remission of Ulcerative Colitis.

Phase 2
Withdrawn
Conditions
Ulcerative Colitis
First Posted Date
2005-11-29
Last Posted Date
2013-12-13
Lead Sponsor
Heidelberg University
Registration Number
NCT00259571
Locations
🇩🇪

Medical Hospital - University of Heidelberg, Heidelberg, Germany

Dose Finding Study for Retarded Phosphatidylcholine in Pancolitis

Phase 2
Completed
Conditions
Ulcerative Colitis
First Posted Date
2005-11-29
Last Posted Date
2007-02-12
Lead Sponsor
Heidelberg University
Target Recruit Count
60
Registration Number
NCT00259558
Locations
🇩🇪

Medical Hospital Unversity Heidelberg, Heidelberg, Germany

Retarded Phosphatidylcholine in Steroid-Dependent Chronic Active Ulcerative Colitis

Phase 2
Completed
Conditions
Phosphatidylcholine
Ulcerative Colitis
First Posted Date
2005-11-29
Last Posted Date
2008-06-05
Lead Sponsor
Heidelberg University
Target Recruit Count
60
Registration Number
NCT00259545
Locations
🇩🇪

University Heidelberg - Medical Department 4 - Gastroenterology, Heidelberg, Germany

Indocyangreen Elimination in Cirrhosis and Acute Liver Failure

Completed
Conditions
Acute Liver Failure
Liver Cirrhosis
First Posted Date
2005-10-27
Last Posted Date
2010-10-11
Lead Sponsor
Heidelberg University
Target Recruit Count
40
Registration Number
NCT00245310
Locations
🇩🇪

University of Heidelberg, Heidelberg, Germany

© Copyright 2025. All Rights Reserved by MedPath